GLP-1 Agonists Enter the Conversation on Psoriatic Disease
GLP-1 agonists are reframing cardiometabolic risk management in psoriatic disease, giving dermatologists a direct tool against the comorbidities they see at every visit.
Topic
Cardiovascular Risk
Topic
Cardiovascular Risk
Childhood Atopic Dermatitis Shows No Cardiovascular Link by Early Adulthood
Childhood atopic dermatitis showed no link to cardiovascular risk in early adulthood, AJMC reports, easing long-held concerns abo…
Cureus Review Compares Long-Term JAK Inhibitor Safety Across Derm and Rheum
A Cureus narrative review compares long-term cardiovascular, thromboembolic and malignancy safety of JAK inhibitors in dermatolog…
Oral Minoxidil for CTD Alopecia: A JAAD Chart Review on Cardiovascular Risk
A retrospective chart review published in JAAD on 8 October 2026 examines oral minoxidil for alopecia in systemic sclerosis, derm…